Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON31910
NL-OMON31910Not yet recruitingNot Applicable

Saliva and serum concentrations of fluconazole in children - Saliva and serum concentrations of fluconazole in children

niversitair Medisch Centrum Groningen0 sites32 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
32
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • •Included are children on oral (with of without enteral tube) or intravenous fluconazole treatment.

Exclusion Criteria

  • •Excluded are children from whom it is impossible to get saliva ,or who have, due to their condition, such a serious mucositis of their oral cavity that saliva is mixed with blood, are excluded.

Investigators

Similar Trials

Not yet recruiting
Phase 4
Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal infectionsfungal infection
NL-OMON51517Radboud Universitair Medisch Centrum15
Active, not recruiting
Phase 1
Exposure to fluconazole in obese patients.Pharmacokinetics of fluconazole in obese subjects.MedDRA version: 20.0Level: PTClassification code 10017533Term: Fungal infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2018-002613-35-NLRadboud university medical centre24
Completed
Phase 2
Comparison of the efficacy of oral fluconazole and oral Terbinafine in the treatment of moderate to severe seborrheic dermatitisSeborrhoeic dermatitis.Seborrhoeic dermatitis
IRCT201102205871N1Gilan University of Medical Sciences64
Active, not recruiting
Phase 1
Determination of voriconazole in Saliva in specific patient populations.patients suffering from an invasive fungal infection, treated with intravenous or oral voriconazole.MedDRA version: 20.1Level: LLTClassification code 10042941Term: Systemic fungal infection NOSSystem Organ Class: 100000004862
EUCTR2012-001396-37-BEniversity Hospitals Leuven, Belgium50
Completed
Not Applicable
Intravenous Fluconazole prophylaxis in preterm neonatesCandidial sepsis.Neonatal candidiasis
IRCT2014051411499N1Research Vice-Canceller of Tabriz University of Medical Sciences100